ROTH JAY W

CEO ROTH JAW bought 62,500 shares at $4.00 on 2026-03-10; stock now $3.44, down 81.0% from 52-week high of $18.10.

CEO Jay W. Roth purchased 62,500 shares at $4.00 on 2026-03-10, his second open-market buy in the past two months at VENU (prior buy on 2026-01-30 returned -7.2% over 30 days). The stock has traded down 40.2% in the 30 days since and 65.7% over 90 days, currently at $3.44 versus the 52-week high of $18.10. The company is unprofitable with net income of $-6,361,487.00 on revenue of $5,384,754.00 (latest quarter), though it reported annual revenue growth of 41.6% year-over-year. His prior trades at this ticker show a 33% well-timed rate at the 90-day mark; most recently, sells on 2025-06-24 and 2025-06-23 returned +7.3% and +4.1% respectively over 30 days but turned negative at 90 days (-0.8% and -4.7%), suggesting late timing in identifying downturns. The repeated purchases into a steep decline warrant close examination of whether they reflect conviction in recovery or liquidity demands.

VENU CEO Jay Roth buys 4,000 shares at $5.23; stock -71.4% from 52-week high, company unprofitable.

CEO Jay Roth purchased 4,000 shares at $5.23 on 2026-02-20, a modest addition to his 9.25M-share position. The purchase occurs as VENU stock trades $5.17, down 71.4% from its 52-week high of $18.10 and down 43.4% over the prior 30 days. The company is unprofitable (net income of $-6.4M in the latest quarter) despite strong revenue growth of 41.6% year-over-year, signaling execution challenges in reaching profitability. In Roth's same-ticker history at VENU, his prior buy on 2026-01-30 outcomes remain unmeasurable, while his four recent sells (June 2025) posted mixed 90-day results: two showed 0.8% gains and two showed -4.7% declines, with 2 of 4 prior trades well-timed at the 90-day mark. The current purchase at a depressed price point follows earlier accumulation activity this year.

VENU CEO Roth buys 5,000 shares at $5.55 as stock down 69.1% from 52-week high

CEO Jay W. Roth purchased 5,000 shares at $5.55 on 2026-01-30, expanding his holdings to 9,249,644 shares. This open-market purchase occurs as VENU trades at $5.59, down 69.1% from its 52-week high of $18.10 and off 30.0% over the past 30 days. The company remains unprofitable (net income of $-6,361,487.00 for the latest quarter) despite reporting annual revenue growth of 41.6%, which adds ambiguity to the signal. Notably, Roth's prior four trades at VENU were all sales (June 2025), with a 50% rate of well-timed execution at the 90-day mark. This buy represents a reversal from that recent selling pattern, though the magnitude (5,000 shares) is modest relative to his 9.25M share position.

CEO Jay W Roth sells 46,506 shares at avg $13.25; stock now $11.70, down 17.7% from 52-week high.

Jay W Roth (CEO, Chairman) executed 4 separate sales totaling 46,506 shares for $616,086.63 on June 23–24, 2025, at a blended average price of $13.25. The sales reduced his holdings by 4.4% to 1,012,623 shares. The stock has since declined to $11.70, trading 17.7% below its 52-week high of $14.21, suggesting the executive sold near elevated price levels relative to recent weakness. The company is unprofitable (full-year net income was negative) and generated only $718,722.00 revenue in the latest quarter, though it reported 41.6% annual revenue growth. The timing of these sales—just above current price—coincides with the stock's recent strength (30-day and 90-day changes both around 32–33%), but the subsequent decline to current levels indicates the sales occurred before a pullback, without additional context to clarify the reason for the liquidation.